Background: After early studies suggested safety and potential for benefit of dexmedetomidine use in neonatal hypoxic-ischemic encephalopathy (HIE), our neonatal intensive care unit (NICU) decided to transition from morphine to dexmedetomidine as our standard sedative during therapeutic hypothermia (TH). The primary aim was to monitor the possible side effects of transitioning from morphine to dexmedetomidine with a primary goal of reducing the days to initiation of enteral feeds to less than 3 days, with the hypothesis that the gastrointestinal motility effects of morphine may have been hindering feeding progress during TH. The secondary aim was to determine rates of hemodynamically significant bradycardia.
Methods: This was a prospective quality improvement study using a retrospective comparison group to determine the comfort, hemodynamic, and early feeding effects of a clinical change in sedation management from morphine to dexmedetomidine. We included infants born at ≥35 weeks of gestation receiving hypothermia for hypoxic-ischemic encephalopathy (HIE) from 2017 to 2023.
Results: Data were collected from 107 infants: 48 morphine, 35 dexmedetomidine, and 24 neither. Heart rate was lower in the morphine and dexmedetomidine groups compared to no sedation. Blood pressures, pain scores, and blanket temperatures were not different between groups. Infants receiving dexmedetomidine initiated enteral feeds earlier than either of the other groups and reached full enteral feeds earlier than the no treatment group but not the morphine group.
Conclusions: This study supports a growing body of literature suggesting dexmedetomidine is a well-tolerated alternative to opioids during hypothermia for HIE.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/19345798251318601 | DOI Listing |
Eur J Pediatr
March 2025
Neonatal Intensive Care Unit, Clínica Universidad de Navarra, Madrid, Spain.
Purpose: This study aims to analyze global prescribing patterns for analgosedation in neonates during four critical care scenarios. The research explores existing patterns, their association with geographic and sociodemographic index (SDI), and adherence to evidence-based practices.
Methods: Data from a 2024 global survey of 924 responses to 28 questions were analyzed, focusing on four items for their high variability: premedication in intubation (Q17), sedation in preterm (Q19) and full-term newborns (Q23), and perinatal asphyxia (Q26).
Vet Anaesth Analg
February 2025
Langford Vets, University of Bristol, Bristol, UK.
A 33-kg adult Labrador Retriever dog presented for investigation of pneumothorax. A computed tomography scan confirmed the diagnosis, and right lateral thoracotomy and lung lobectomy were performed under general anaesthesia. During surgery, anaesthesia was maintained with a propofol constant-rate intravenous (IV) infusion (premedication with methadone and dexmedetomidine) and IV atracurium was given to facilitate surgery.
View Article and Find Full Text PDFFront Pharmacol
February 2025
Department of Cardiac Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Aim: This study aimed to analyze the effects of perioperative morphine and fentanyl use on delirium, length of ICU stay, and in-hospital mortality after cardiac surgery.
Methods: This cohort study retrieved the data of 4,596 patients admitted to ICU after cardiac surgery in MIMIC-IV database from 2008 to 2019. The primary outcome was postoperative delirium.
Top Companion Anim Med
March 2025
Faculty of Veterinary Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
This study compared the cardiovascular response to surgery and postoperative pain between an opioid-free protocol and two opioid-based protocols in cats undergoing elective ovariohysterectomy. Cats were randomly allocated into three intramuscular premedication treatments: DEX (dexmedetomidine 7 µg/kg, n = 12), DEXMET (dexmedetomidine 7 µg/kg + methadone 0.3 mg/kg, n = 13) and DEXMOR (dexmedetomidine 7 µg/kg + morphine 0.
View Article and Find Full Text PDFJ Perinatol
February 2025
Division of Neonatology, Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone, 550 1st Avenue, New York, NY, 10016, USA.
Objective: To compare neurodevelopmental outcomes using Bayley Scales of Infant Development (BSID), between encephalopathic neonates undergoing therapeutic hypothermia (TH), sedated with either continuous dexmedetomidine or intermittent morphine.
Study Design: Retrospective, observational cohort study including encephalopathic neonates born between 2014 - 2022 that underwent TH at two Regional Perinatal Centres, and completed neurodevelopmental follow-up assessments.
Results: There were no significant differences in demographics or short-term neurologic outcomes between morphine (n = 30) and dexmedetomidine (n = 32) groups.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!